This book compares national and centralised procedure practices and key performance metrics
including current approval times review practices and pharmacovigilance standards in the
seven Gulf States. Opportunities for an improved regulatory system are identified which if
fully implemented could have a significant impact on patients' access to new medicines.The
Persian Gulf represents the next growth market for the global biopharmaceutical industry but to
date there has been limited information about the regulatory review processes employed in these
countries. A thorough examination of the strategies currently being implemented by the Gulf
States is considered critical to the future regulatory environment in this
region.Pharmaceutical Regulatory Environment: Challenges & Opportunities in the Gulf Region is
a must read for those interested in pharmaceutical regulation in the Gulf region.
